0001493152-23-027061.txt : 20230807 0001493152-23-027061.hdr.sgml : 20230807 20230807172541 ACCESSION NUMBER: 0001493152-23-027061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230807 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waltzman Roger J. CENTRAL INDEX KEY: 0001678987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 231148609 MAIL ADDRESS: STREET 1: C/O JAGUAR ANIMAL HEALTH, INC. STREET 2: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (646) 427-2727 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 4 1 ownership.xml X0508 4 2023-08-07 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001678987 Waltzman Roger J. C/O INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 0 1 0 0 Chief Medical Officer 0 Stock Option (Right to Buy) 1.85 2023-08-07 4 A 0 90000 0 A 2033-08-07 Common Stock 90000 90000 D The stock option vests and becomes exercisable as to one-third of the total shares on August 7, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on August 7, 2026. /s/ Nir Sassi, Attorney-in-Fact for Roger J. Waltzman 2023-08-07